Gilead Sciences, Inc. (GILD) 的整體財務健康評級為 B+ 綜合評分為 0 （滿分5分）.
這表明公司面臨一些值得關注的財務挑戰. 評級截至 2026-04-07.
| 日期 | 評級 | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-04-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-04-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-04-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-04-01 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-31 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-27 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
